Edwards Lifesciences announces sale of Critical Care unit for a record-breaking $4.2 billion

Edwards Lifesciences Sells Critical Care Unit for $4.2 Billion

Edwards Lifesciences, a prominent player in the medical technology sector, has announced the sale of its Critical Care unit for a staggering $4.2 billion. The move underscores the company's efforts to enhance operational efficiency and capitalize on core competencies.

This strategic decision is projected to have a profound impact on Edwards Lifesciences' financial standing and market presence. The sale of the Critical Care unit signifies a pivotal moment in the company's growth trajectory and strategic direction.